Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-21-001545

Director sold 52,500 shares at an average $11.92 ($625,775)

  • Director acquired 52,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BLOCK STEPHEN A · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-15 Exercise or conversion : show line 1 in the form +32,500 $1.92 $62,400 49,167 D
2021-03-15 Sale : show line 2 in the form −32,500 $11.15 $362,375 16,667 D
2021-03-16 Exercise or conversion : show line 3 in the form +20,000 $2.61 $52,100 36,667 D
2021-03-16 Sale : show line 4 in the form −20,000 $13.17 $263,400 16,667 D
Open-market sales · 52,500 sh · avg $11.92 · $625,775

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-03-15 Exercise or conversion : show line 5 in the form Stock Options (right to buy) −32,500 0 D
2021-03-16 Exercise or conversion : show line 6 in the form Stock Options (right to buy) −20,000 0 D
Loading xslF345X03/form4-03172021_030350.xml…